16.08.18|CTechNasdaq-listed Sol-Gel is a clinical-stage company developing topical products for skin conditions
31.08.17|Dror ReichThe clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology
15.08.17|Golan HazaniSol-Gel approached potential underwriters. It aims to go public before the end of the year